Dr. Deepak Rawtani, Aliasgar F. Shahiwala, P. Prajapati
{"title":"Editorial: Advances in self-assembled nanocarriers for drug delivery","authors":"Dr. Deepak Rawtani, Aliasgar F. Shahiwala, P. Prajapati","doi":"10.3389/fnano.2022.1020414","DOIUrl":null,"url":null,"abstract":"Self-assembled nanocarriers are attracting increasing attention from drug delivery scientists due to their ability to provide higher efficacy with fewer side effects. Creating such a system requires carefully selecting atoms or molecules that can be assembled spontaneously by hydrogen bonding, electrostatic, hydrophobic, and van der Waal interactions to form a stable, well-defined structure with the desired physicochemical and biological properties. Self-assembled nanocarriers comprise a wide range of systems, including surfactant-based nanoparticles such as micelles, liposomes, niosomes, polymeric nanoparticles, carbon nanotubes, and metal nanoclusters (Figure 1). Biomedical applications of these systems include drug, gene, and vaccine delivery, as well as tissue engineering. Combined with advanced materials science and the latest technologies, such systems could provide promising solutions to many unmet clinical needs. The Research Topic Advances in Self-Assembled Nanocarriers for Drug Delivery includes four articles in total: two reviews and two original research papers. The review by Paliwal et al. discusses the current state of, and new trends in, selfassembled nanocarriers (Paliwal et al.). They highlight some of the innovations in these nanocarriers and their applications, such as in prolonging drug action, improving bioavailability, avoiding drug resistance, and enhancing cellular uptake. In addition to being interesting to read, this review also provides the most up-to-date status of the self-assembled nanocarriers in the preclinical, clinical, and market phases. Despite the availability of small-molecule antiviral treatments, there was a clear unmet clinical need for them during the COVID pandemic caused by the SARS-CoV-2 virus. Nanoviricide’s Biopolymer (NV-CoV-2) with covalently attached polyethylene glycol and alkyl pendants is a platform technology developed by NanoViricides, Inc. NV-CoV-2 are uniquemicelles with up to 1,200 chemically attached ligands on their surface that can bind and inactivate viruses. A mini-review published in this Research Topic by Chakraborty OPEN ACCESS","PeriodicalId":34432,"journal":{"name":"Frontiers in Nanotechnology","volume":" ","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Nanotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fnano.2022.1020414","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Self-assembled nanocarriers are attracting increasing attention from drug delivery scientists due to their ability to provide higher efficacy with fewer side effects. Creating such a system requires carefully selecting atoms or molecules that can be assembled spontaneously by hydrogen bonding, electrostatic, hydrophobic, and van der Waal interactions to form a stable, well-defined structure with the desired physicochemical and biological properties. Self-assembled nanocarriers comprise a wide range of systems, including surfactant-based nanoparticles such as micelles, liposomes, niosomes, polymeric nanoparticles, carbon nanotubes, and metal nanoclusters (Figure 1). Biomedical applications of these systems include drug, gene, and vaccine delivery, as well as tissue engineering. Combined with advanced materials science and the latest technologies, such systems could provide promising solutions to many unmet clinical needs. The Research Topic Advances in Self-Assembled Nanocarriers for Drug Delivery includes four articles in total: two reviews and two original research papers. The review by Paliwal et al. discusses the current state of, and new trends in, selfassembled nanocarriers (Paliwal et al.). They highlight some of the innovations in these nanocarriers and their applications, such as in prolonging drug action, improving bioavailability, avoiding drug resistance, and enhancing cellular uptake. In addition to being interesting to read, this review also provides the most up-to-date status of the self-assembled nanocarriers in the preclinical, clinical, and market phases. Despite the availability of small-molecule antiviral treatments, there was a clear unmet clinical need for them during the COVID pandemic caused by the SARS-CoV-2 virus. Nanoviricide’s Biopolymer (NV-CoV-2) with covalently attached polyethylene glycol and alkyl pendants is a platform technology developed by NanoViricides, Inc. NV-CoV-2 are uniquemicelles with up to 1,200 chemically attached ligands on their surface that can bind and inactivate viruses. A mini-review published in this Research Topic by Chakraborty OPEN ACCESS
自组装纳米载体由于具有高疗效、低副作用的特点,正日益受到药物传递科学家的关注。创建这样的系统需要仔细选择可以通过氢键、静电、疏水和范德华相互作用自发组装的原子或分子,以形成具有所需物理化学和生物特性的稳定、定义良好的结构。自组装纳米载体包括各种各样的系统,包括基于表面活性剂的纳米颗粒,如胶束、脂质体、纳米体、聚合物纳米颗粒、碳纳米管和金属纳米团簇(图1)。这些系统的生物医学应用包括药物、基因和疫苗输送,以及组织工程。结合先进的材料科学和最新技术,这种系统可以为许多未满足的临床需求提供有希望的解决方案。研究课题“Advances in self - assemble nanotechnology for Drug - Delivery”包括四篇综述和两篇原创研究论文。Paliwal等人的综述讨论了自组装纳米载体的现状和新趋势(Paliwal等人)。他们强调了这些纳米载体及其应用的一些创新,如延长药物作用、提高生物利用度、避免耐药性和增强细胞摄取。除了有趣的阅读,这篇综述还提供了自组装纳米载体在临床前、临床和市场阶段的最新状态。尽管有小分子抗病毒治疗,但在由SARS-CoV-2病毒引起的COVID大流行期间,对这些治疗的临床需求显然没有得到满足。纳米杀毒剂的生物聚合物(NV-CoV-2)是由NanoViricides公司开发的一种平台技术,其共价附着的聚乙二醇和烷基悬垂物。NV-CoV-2是一种独特的胶束,其表面有多达1200个化学附着的配体,可以结合和灭活病毒。Chakraborty OPEN ACCESS在本研究主题上发表的一篇小型综述